• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Novartis Poaches GSK Veteran as New Sandoz CEO

cafead

Administrator
Staff member
  • cafead   Apr 24, 2019 at 11:52: AM
via GlaxoSmithKline veteran Richard Saynor is coming home to Sandoz. Saynor was named the new chief executive officer of the Novartis’ subsidiary on Tuesday.

For the past nine years, Saynor has been with GSK, most recently serving as senior vice president and global head of classic and established medicines at the U.K. pharma giant.

article source